|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/16 | |
| A61K 9/00 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3318267 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16818303.6 |
| Europos patento paraiškos padavimo data | 2016-07-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2016/007203 |
| Data | 2016-07-04 |
| (87) | Numeris | WO 2017/003270 |
| Data | 2017-01-05 |
| (30) | Numeris | Data | Šalis |
| 201562187867 P | 2015-07-02 | US | |
| 20150187297 | 2015-12-28 | KR |
| (72) |
LEE, Jin-Kyung, KR
BYUN, Han-Yeul, KR
JUNG, Myung-Eun, KR
LEE, Kyu-Hyun, KR
|
| (73) |
Medigenebio Corporation,
107 Ihyeon-ro 30beon-gil Giheung-gu Yongin-si, Gyeonggi-do 446-855,
KR
Green Cross Corporation, (Bojeong-dong) 107 Ihyeon-ro 30beon-gil Giheung-gu, Yongin-si, Gyeonggi-do 16924, KR |
| (54) | HUNTER SYNDROME THERAPEUTIC AGENT |
| HUNTER SYNDROME THERAPEUTIC AGENT |